In the News with Mike Dakkak
Kim Witczak joins ITN to discuss the inner workings of the FDA and what should change.
Follow Kim on Twitter at https://x.com/woodymatters.
Get started with Graith Care at https://www.graithcare.com. Use promo …
Continue ReadingThe FDA said on Thursday that it had formally approved remdesivir as the first drug to treat Covid-19. https://t.co/x2vLRvhAhe
— The New York Times (@nytimes) October 22, 2020
The Food & Drug Administration (FDA) has approved Gilead Sciences’ drug Remedesivir …
Continue ReadingResearchers studied 2,500 Covid19 patients in the Henry Ford Health System in Michigan and found “clear benefit” to using Hydroxychloroquine as treatment for the virus.
Of the patients, 2,000 of were given Hydroxychloroquine and/or the antibiotic Azithromycin.
Researchers …
Continue ReadingThe House of Representatives has passed a bill giving patients the ability to try experimental drugs and treatments that have not been approved by the FDA, this week. The so-called right-to-try bill gives very ill and terminally ill patients the …
Continue ReadingThe FDA has approved the first blood test that helps doctors diagnose traumatic brain injuries in the U.S. Banyan Biomarkers, the test’s maker, can commercialize its test and the approval now gives the company an inside track on the goal …
Continue ReadingThe FDA has announced new requirements for the labeling of prescription cough and cold medicines that contain opioids, indicating that they should no longer be given to children under the age of 18. The FDA says the new requirements …
Continue Reading